HUMAN PARVOVIRUS B19 INFECTION IN BLOOD-DONORS

被引:52
作者
TSUJIMURA, M [1 ]
MATSUSHITA, K [1 ]
SHIRAKI, H [1 ]
SATO, H [1 ]
OKOCHI, K [1 ]
MAEDA, Y [1 ]
机构
[1] FUKUOKA RED CROSS, CTR BLOOD, FUKUOKA 818, JAPAN
关键词
D O I
10.1111/j.1423-0410.1995.tb02595.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using an immunodiffusion assay, we tested all of the blood units donated at the Fukuoka Red Cross Blood Center from June 1991 to July 1994 for B19 antigen. Over this 3-year trial period, we detected 16 viremic cases out of approximately 560,000 blood donors. Interestingly, most of the viremic donors (15 out of 16) were detected between February 1992 and January 1993, which coincided with a local erythemia infectiosum epidemic in the Fuhuoka area (December 1991 to August 1992). In particular, we detected 4 cases of viremia in March 1992, which was the peak of the erythema infectiosum epidemic. The incidence of B19 viremia in this peak period was approximately 1/4,000. The viremic donors ranged in age from 17 to 45 years, and most (11/16) were between 31 and 39 years old. By ELISA, using virus particles purified from viremic donor plasma as antigen, we analyzed the prevalence of B19-specific antibody among blood donors. The antibody-positive rate was approximately 40% in donors 16-30 years old, gradually increased in middle age, and reached apeak of 92% in donors more than 61 years old.
引用
收藏
页码:206 / 212
页数:7
相关论文
共 32 条
[11]  
DUNCAN JR, 1983, LANCET, V2, P14
[12]   DETECTION OF ANTIBODIES TO HEPATITIS-C VIRUS (HCV) STRUCTURAL PROTEINS IN ANTI-HCV-POSITIVE SERA BY AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY USING SYNTHETIC PEPTIDES AS ANTIGENS [J].
ISHIDA, C ;
MATSUMOTO, K ;
FUKADA, K ;
MATSUSHITA, K ;
SHIRAKI, H ;
MAEDA, Y .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (04) :936-940
[13]   SEROLOGICALLY PROVED INTRAUTERINE INFECTION WITH PARVOVIRUS [J].
KNOTT, PD ;
WELPLY, GAC ;
ANDERSON, MJ .
BRITISH MEDICAL JOURNAL, 1984, 289 (6459) :1660-1660
[14]   DETECTION OF HUMAN PARVOVIRUS B19 DNA BY USING THE POLYMERASE CHAIN-REACTION [J].
KOCH, WC ;
ADLER, SP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (01) :65-69
[15]  
KURTZMAN GJ, 1988, LANCET, V2, P1159
[16]   CHRONIC BONE-MARROW FAILURE DUE TO PERSISTENT B19-PARVOVIRUS INFECTION [J].
KURTZMAN, GJ ;
OZAWA, K ;
COHEN, B ;
HANSON, G ;
OSEAS, R ;
YOUNG, NS .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (05) :287-294
[17]   DETECTION OF PARVOVIRUS-B19 IN DONATED BLOOD - A MODEL SYSTEM FOR SCREENING BY POLYMERASE CHAIN-REACTION [J].
MCOMISH, F ;
YAP, PL ;
JORDAN, A ;
HART, H ;
COHEN, BJ ;
SIMMONDS, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (02) :323-328
[18]   DOT BLOT HYBRIDIZATION ASSAY OF B19-VIRUS DNA IN CLINICAL SPECIMENS [J].
MORI, J ;
FIELD, AM ;
CLEWLEY, JP ;
COHEN, BJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (03) :459-464
[19]  
MORTIMER PP, 1983, LANCET, V2, P482
[20]   HYPOTHESIS - THE APLASTIC CRISIS OF HEREDITARY SPHEROCYTOSIS IS DUE TO A SINGLE TRANSMISSIBLE AGENT [J].
MORTIMER, PP .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (04) :445-448